Study title:
J Nucl Med. 2005 Apr;46(4):560-6.
Characterization of hyperinsulinism in infancy assessed with PET and
18F-fluoro-L-DOPA.
Ribeiro MJ, De Lonlay P, Delzescaux T, Boddaert N, Jaubert F, Bourgeois S, Dollé
F, Nihoul-Fékété C, Syrota A, Brunelle F.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Nutritional and Metabolic Diseases [C18]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: FLUDEOXYGLUCOSE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|